Carotid Atherosclerosis,Middle Cerebral Artery Stenosis, Homocysteine
Conditions
Interventions
Hypertension with Homocysteine:extended release nifedipine tablets+Vitamin B6+Vitamin B12+folic acid/berberine/berberine+folic acid
Middle Cerebral Artery Stenosis:Atorvastatin+Aspirin/Aspirin+berberine
Carotid atherosclerosis:Atorvastatin+Aspirin/Aspirin+berberine
Sponsors
The First Central Hospital of Baoding
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 18-80 years; (2) Patients agree and sign an informed consent.
Exclusion criteria
Exclusion criteria: (1) The allergic and other server adverse reactions to drugs in the treatment; (2) Complication severe infection or critical illness; (3) Severe complications including cancer, cardiopulmonary insufficiency, impaired liver function, kidney injury, or other immune diseases; (4) Consistent with the indications of thrombolysis or surgery; (5) Patients could not follow the program or incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Homocysteine;Middle Cerebral Artery Stenosis;Carotid plaque;Analysis of intestinal flora gene chip; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose, triglyceride, total cholesterol, low density lipoprotein; | — |
Countries
China
Contacts
Public ContactPei Wang
The First Central Hospital of Baoding
Outcome results
None listed